top of page


Update on Takeover Process
Edison Group has provided a year-end update on EMIS Group plc confirming that FY22 revenue and adjusted operating profit were in line...

Adam Strydom
Jan 18, 20241 min read


Strong Finish to FY22 Prompts Further Upgrade
4imprint's update shows the group continuing to trade strongly through Q422 and Edison Group upgraded their estimates again. FY22 revenue...

Adam Strydom
Jan 18, 20241 min read


SUPR Takes Majority Interest in Indirect Portfolio
Supermarket Income REIT (SUPR) has acquired an additional 25.5% beneficial interest in the Sainsbury’s Reversion Portfolio (SRP) from its...

Adam Strydom
Jan 18, 20241 min read


Order Momentum Maintained in Q422
Esker Inc’s Q422 revenue update confirmed that the company hit the mid-point of its revenue guidance for FY22, despite the already...

Adam Strydom
Jan 18, 20241 min read


Strong H222 with Good Visibility for FY23
XP Power’s FY22 trading update confirmed that its H222 performance was significantly stronger than H122 as supply chain conditions...

Adam Strydom
Jan 18, 20241 min read


Starting 2023 with $6.6m Telecom IoT Win
WANdisco’s proprietary replication technology enables its customers to solve critical data-management challenges created by the shift to...

Adam Strydom
Jan 18, 20241 min read


Cresemba Milestone Payment Triggered
Basilea Pharmaceutica has announced that it has received a sales-related milestone payment of CHF20m from its US licensing partner...

Adam Strydom
Jan 18, 20241 min read


Vodafone Hungary Acquisition Finalised
4iG Nyrt. is a regional ICT/telecoms group, based in Hungary and focused on two core areas: telecoms and infrastructure, and investments...

Adam Strydom
Jan 18, 20241 min read


Boosting Presence in High-Growth Cyber Security
TINEXTA S.P.A.’s binding agreement to acquire an initial 20% stake in Defence Tech Holding (DTH) will provide a significant presence in a...

Adam Strydom
Jan 18, 20241 min read


Third Leg of Strategy Executed With Debt Repayment
Basilea Pharmaceutica is focused on treating infectious diseases. Basilea has announced the full repayment of the CHF113.8m outstanding...

Adam Strydom
Jan 18, 20241 min read
All
bottom of page